Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
9.98
+1.72 (20.82%)
At close: Dec 24, 2024, 12:59 PM
10.30
+0.32 (3.21%)
Pre-market: Dec 26, 2024, 5:10 AM EST
Ensysce Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Ensysce Biosciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for ENSC.
Recommendation Trends
Rating | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $135 → $105 | Strong Buy | Maintains | $135 → $105 | +952.10% | Sep 25, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +1,252.71% | Jul 3, 2023 |
Lake Street | Lake Street | Strong Buy Maintains $14,400 → $1,440 | Strong Buy | Maintains | $14,400 → $1,440 | +14,328.86% | Nov 17, 2022 |
Lake Street | Lake Street | Strong Buy Initiates $14,400 | Strong Buy | Initiates | $14,400 | +144,188.58% | Nov 30, 2021 |
Financial Forecast
Revenue This Year
2.50M
from 2.23M
Increased by 12.04%
Revenue Next Year
n/a
from 2.50M
EPS This Year
-12.70
from -70.40
EPS Next Year
-13.01
from -12.70
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 4.2M | n/a | 84.0M | |
Avg | 2.5M | n/a | 47.8M | |
Low | 882,000 | n/a | 13.4M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 88.3% | - | - | |
Avg | 12.0% | - | - | |
Low | -60.5% | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -13.07 | -10.71 | 88.52 |
Avg | -12.70 | -13.01 | 85.99 |
Low | -12.20 | -14.99 | 82.61 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.